Key points are not available for this paper at this time.
different pathways and provides a comprehensive review of the most recent updates on COX-2 inhibitors as potential anticancer candidates. This review aims to spark fresh thinking in the pursuit of more logical COX-2 inhibitor designs that may effectively treat cancer.
Asmaa E. Kassab (Wed,) studied this question.